Retour
Fourchette du Jour
3,18 €
3,40 €
Fourchette 52 Semaines
0,53 €
5,78 €
Volume
2 291 609
Moyenne 50J / 200J
4,21 €
/
2,36 €
Clôture Précédente
3,04 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 22,3 | 0,4 |
| P/B | — | 2,9 |
| ROE % | — | 3,8 |
| Net Margin % | 8,1 | 3,9 |
| Rev Growth 5Y % | -8,0 | 10,0 |
| D/E | — | 0,2 |
Points Clés
Revenue declined -8,02% annually over 5 years
Earnings grew 2629,20% over the past year
Generating 127,01M in free cash flow
PEG of 0,01 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 7,70%
Cash machine — converts 528,83% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
-8,02%
Revenue (1Y)-15,72%
Earnings (1Y)2629,20%
FCF Growth (3Y)-16,73%
Qualité
Return on Equity
N/A
ROIC26,51%
Net Margin8,11%
Op. Margin40,10%
Sécurité
Debt / Equity
N/A
Current Ratio1,13
Interest Coverage3,63
Valorisation
P/E Ratio
22,34
P/B RatioN/A
EV/EBITDA7,74
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -15,72% | Revenue Growth (3Y) | -18,21% |
| Earnings Growth (1Y) | 2629,20% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -8,02% | Earnings Growth (5Y) | -53,83% |
| Profitability | |||
| Revenue (TTM) | 296,15M | Net Income (TTM) | 24,02M |
| ROE | N/A | ROA | 6,05% |
| Gross Margin | 99,36% | Operating Margin | 40,10% |
| Net Margin | 8,11% | Free Cash Flow (TTM) | 127,01M |
| ROIC | 26,51% | FCF Growth (3Y) | -16,73% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,13 |
| Interest Coverage | 3,63 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 22,34 | P/B Ratio | N/A |
| P/S Ratio | 1,81 | PEG Ratio | 0,01 |
| EV/EBITDA | 7,74 | Dividend Yield | 0,00% |
| Market Cap | 536,46M | Enterprise Value | 918,81M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 296,15M | 351,41M | 442,74M | 410,60M | 413,75M |
| Net Income | 24,02M | 880 000,0 | -1,00B | 175,07M | 528,45M |
| EPS (Diluted) | 0,15 | 0,01 | -6,45 | 0,96 | 3,21 |
| Gross Profit | 294,27M | 343,86M | 436,59M | 409,18M | 343,35M |
| Operating Income | 118,76M | 93,12M | -945,43M | 250,34M | 232,26M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 396,90M | 350,91M | 471,07M | 1,10B | 1,13B |
| Total Liabilities | 658,74M | 652,24M | 817,37M | 448,14M | 521,02M |
| Shareholders' Equity | -261,83M | -301,34M | -346,30M | 652,38M | 605,91M |
| Total Debt | 597,80M | 599,48M | 715,54M | 415,92M | 475,80M |
| Cash & Equivalents | 215,46M | 88,56M | 92,15M | 656,20M | 620,13M |
| Current Assets | 274,18M | 182,37M | 233,29M | 780,63M | 745,23M |
| Current Liabilities | 242,22M | 38,85M | 276,10M | 25,53M | 161,70M |